24 Oct GLP-1 Safety Information
GLP-1 Safety and Side Effect Profile
A Patient Management Guide for Semaglutide & Tirzepatide Users
Authoritative Source & Safety Warning: Consult your prescribing physician immediately if any severe symptoms arise.
I. Managing Common Side Effects (Gastrointestinal)
The majority of side effects are mild to moderate and related to slowed digestion. They typically improve as your body adjusts to the medication dosage.
Prevalence of Common GI Side Effects
Percentage of patients reporting each issue during the initial phase of therapy.
The Key to Management
The core strategy is to Eat Small, Bland, and Slow. High-fat or overly large meals exacerbate nausea due to delayed gastric emptying.
- Sip clear, cool fluids.
- Avoid fried, greasy foods.
- Increase fiber and water for constipation.
Nausea (~68% Prevalence)
Eat smaller, blander meals. Avoid high-fat, fried, or overly sweet foods, which can slow digestion further. Sip clear fluids or ginger tea slowly.
Diarrhea (Common Early)
Stay hydrated with electrolytes. Avoid caffeine and very high-fiber foods temporarily. OTC anti-diarrheal medication may be used under a doctor’s guidance.
Constipation (Common Later)
Increase water intake significantly. Incorporate a balanced amount of fiber (vegetables, whole grains). Consider a daily fiber supplement or stool softener if advised by your provider.
Abdominal Pain (Mild & Transient)
Often related to gas or indigestion. Try walking or gentle movement. If the pain is severe, persistent, or radiates to the back, contact your provider immediately.
II. Serious and Rare Safety Warnings (Immediate Action Required)
While rare, these conditions require immediate patient awareness. If you experience any of these symptoms, discontinue the medication and seek medical help.
Thyroid C-Cell Tumors (MTC)
Absolute Contraindication
Do not use if you have a personal or family history of **Medullary Thyroid Carcinoma (MTC)** or **MEN 2** syndrome.
- Hoarseness or persistent cough.
- Lump or swelling in the neck.
- Trouble swallowing.
Pancreatitis (Inflammation)
Severe, persistent pain requires immediate care.
A rare but severe risk. If suspected, **STOP** the medication.
- Severe, persistent abdominal pain.
- Pain that radiates to the back.
- Pain accompanied by vomiting.
Acute Kidney Injury (AKI)
High Risk from Severe Dehydration
Caused by uncontrolled vomiting/diarrhea. **Prevention is hydration.**
- Report persistent vomiting/diarrhea immediately.
- Monitor urine output (reduced output is a sign).
Gallbladder Issues (Gallstones)
Associated with Rapid Weight Loss
Rapid weight loss itself can increase the risk of developing gallstones (Cholecystitis).
- Pain in the upper right side of the abdomen.
- Fever or chills.
- Yellowing of the skin or eyes (Jaundice).
III. Important Drug Interactions and Contraindications
GLP-1 medications may affect other drugs. Always provide a full list of all medications to your provider.
| Risk Factor | Reason for Concern | Prescribing Guidance |
|---|---|---|
| Diabetic Patients (Insulin/Sulfonylurea) | Increased risk of severe hypoglycemia (low blood sugar). | Dosage of insulin/sulfonylurea **must be reduced** before starting GLP-1. Monitor glucose frequently. |
| Oral Medications (e.g., Contraceptives) | GLP-1s slow gastric emptying, potentially delaying absorption of oral drugs. | Discuss all oral medications. May require taking them earlier than the GLP-1 dose. |
| Pre-Existing Severe GI Disease | Not studied in patients with severe gastroparesis or inflammatory bowel disease. | Use is generally **not recommended** due to the mechanism of action on gastric motility. |
IV. When to Call Your Healthcare Provider Immediately
- Severe, persistent abdominal pain (Pancreatitis).
- Lump in neck or persistent hoarseness (MTC symptoms).
- Signs of a severe allergic reaction (hives, swelling of face/throat, trouble breathing).
- Severe vomiting or diarrhea that lasts longer than 24 hours (Dehydration/AKI risk).